Alkermes Plc (ALKS)
48.85
+0.52
(+1.08%)
USD |
NASDAQ |
Aug 24, 16:00
48.85
0.00 (0.00%)
After-Hours: 19:58
Alkermes Debt to Equity Ratio : 0.8695 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8695 |
| March 31, 2026 | 0.903 |
| December 31, 2025 | 0.0385 |
| September 30, 2025 | 0.0413 |
| June 30, 2025 | 0.0447 |
| March 31, 2025 | 0.049 |
| December 31, 2024 | 0.0516 |
| September 30, 2024 | 0.2833 |
| June 30, 2024 | 0.2866 |
| March 31, 2024 | 0.295 |
| December 31, 2023 | 0.3095 |
| September 30, 2023 | 0.284 |
| June 30, 2023 | 0.3042 |
| March 31, 2023 | 0.3919 |
| December 31, 2022 | 0.3635 |
| September 30, 2022 | 0.3887 |
| June 30, 2022 | 0.3791 |
| March 31, 2022 | 0.3862 |
| December 31, 2021 | 0.3741 |
| September 30, 2021 | 0.383 |
| June 30, 2021 | 0.3867 |
| March 31, 2021 | 0.4082 |
| December 31, 2020 | 0.3844 |
| September 30, 2020 | 0.3556 |
| June 30, 2020 | 0.368 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3708 |
| December 31, 2019 | 0.268 |
| September 30, 2019 | 0.2743 |
| June 30, 2019 | 0.2711 |
| March 31, 2019 | 0.2709 |
| December 31, 2018 | 0.2385 |
| September 30, 2018 | 0.2432 |
| June 30, 2018 | 0.2421 |
| March 31, 2018 | 0.243 |
| December 31, 2017 | 0.234 |
| September 30, 2017 | 0.2375 |
| June 30, 2017 | 0.2351 |
| March 31, 2017 | 0.2327 |
| December 31, 2016 | 0.2345 |
| September 30, 2016 | 0.2361 |
| June 30, 2016 | 0.2791 |
| March 31, 2016 | 0.2755 |
| December 31, 2015 | 0.2663 |
| September 30, 2015 | 0.2584 |
| June 30, 2015 | 0.2536 |
| March 31, 2015 | 0.2509 |
| December 31, 2014 | 0.2563 |
| September 30, 2014 | 0.2696 |
| June 30, 2014 | 0.2671 |
| March 31, 2014 | 0.2708 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Amarin Corp. Plc | 0.0118 |
| Jazz Pharmaceuticals Plc | 0.9183 |
| Prothena Corp. Plc | 0.0244 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Biogen, Inc. | 0.4433 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.393B |
| Total Liabilities (Quarterly) | 2.585B |
| Shareholders Equity (Quarterly) | 1.809B |
| Current Ratio | 2.300 |
| Net Debt Paydown Yield | -3.41% |